- Study Objective: To evaluate the efficacy and safety of a biosimilar for treating PNH and aHUS.
- Understanding PNH and aHUS: PNH and aHUS are life-threatening blood diseases that can lead to severe complications.
- Importance of Biosimilars: Biosimilars provide more affordable treatment options and can prevent medicine shortages.
- Clinical Trial Details:
- The trial is designed to offer an alternative to high-cost medications, ensuring wider patient access and affordability
- An independent ethics committee has approved this clinical trial.
- Participants will be reimbursed for their time.
Call us on 1800 243 733 to discuss your eligibility today!